Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
June 23, 2012
Bevacizumab for glioblastoma multiforme after traumatic subarachnoid hemorrhage
Rimas V Lukas, Fernando Goldenberg, Martin K Nicholas
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
July 11, 2015
ROS1 rearranged non-small cell lung cancer brain metastases respond to low dose radiotherapy
Rimas V Lukas, Yasmin Hasan, Martin K Nicholas, et al.
Neurological Research
|
January 17, 2015
Paraneoplastic nerve hyperexcitability
Jennifer A Liebenthal, Kourosh Rezania, Martin K Nicholas, et al.
Advances in Radiation Oncology
|
July 26, 2017
An analysis of prognostic factors associated with recurrence in the treatment of atypical meningiomas
Christian Fernandez, Martin K Nicholas, Herbert H Engelhard, et al.
Journal of Neuro-Oncology
|
August 25, 2017
Association between hospital volume and receipt of treatment and survival in patients with glioblastoma
Matthew Koshy, David J Sher, Michael Spiotto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 7, 2023
Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
Henry S Friedman, Michael D Prados, Patrick Y Wen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 2, 2009
Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma
Henry S Friedman, Michael D Prados, Patrick Y Wen, et al.
The Oncologist
|
December 15, 2010
Corticosteroid use in patients with glioblastoma at first or second relapse treated with bevacizumab in the BRAIN study
James J Vredenburgh, Timothy Cloughesy, Meghna Samant, et al.
Neuro-Oncology
|
November 19, 2010
Response as a predictor of survival in patients with recurrent glioblastoma treated with bevacizumab
Michael Prados, Timothy Cloughesy, Meghna Samant, et al.
Neuro-Oncology
|
May 12, 2011
Neurocognitive function in patients with recurrent glioblastoma treated with bevacizumab
Jeffrey S Wefel, Timothy Cloughesy, James L Zazzali, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
June 23, 2012
Bevacizumab for glioblastoma multiforme after traumatic subarachnoid hemorrhage
Rimas V Lukas, Fernando Goldenberg, Martin K Nicholas
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
July 11, 2015
ROS1 rearranged non-small cell lung cancer brain metastases respond to low dose radiotherapy
Rimas V Lukas, Yasmin Hasan, Martin K Nicholas, et al.
Neurological Research
|
January 17, 2015
Paraneoplastic nerve hyperexcitability
Jennifer A Liebenthal, Kourosh Rezania, Martin K Nicholas, et al.
Advances in Radiation Oncology
|
July 26, 2017
An analysis of prognostic factors associated with recurrence in the treatment of atypical meningiomas
Christian Fernandez, Martin K Nicholas, Herbert H Engelhard, et al.
Journal of Neuro-Oncology
|
August 25, 2017
Association between hospital volume and receipt of treatment and survival in patients with glioblastoma
Matthew Koshy, David J Sher, Michael Spiotto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 7, 2023
Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
Henry S Friedman, Michael D Prados, Patrick Y Wen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 2, 2009
Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma
Henry S Friedman, Michael D Prados, Patrick Y Wen, et al.
The Oncologist
|
December 15, 2010
Corticosteroid use in patients with glioblastoma at first or second relapse treated with bevacizumab in the BRAIN study
James J Vredenburgh, Timothy Cloughesy, Meghna Samant, et al.
Neuro-Oncology
|
November 19, 2010
Response as a predictor of survival in patients with recurrent glioblastoma treated with bevacizumab
Michael Prados, Timothy Cloughesy, Meghna Samant, et al.
Neuro-Oncology
|
May 12, 2011
Neurocognitive function in patients with recurrent glioblastoma treated with bevacizumab
Jeffrey S Wefel, Timothy Cloughesy, James L Zazzali, et al.
Page
of 1